1-15 of 15
Nitya Nathwani, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patient Perspectives on Treatment Experience and Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma

Nitya Nathwani, MD, Jill A. Bell, PhD MS, Dasha Cherepanov, France Ginchereau Sowell, PhD MA, Rachel Shah, BS, Kelly McCarrier, PhD MPH, Parameswaran Hari, MD MRCP
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-137054
Published: 2020
Journal Articles

Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Efficacy and Safety Analysis of the Safety Run-in Population of Griffin

Peter M. Voorhees, Cesar Rodriguez, MD, Brandi Reeves, MD, Nitya Nathwani, MD, Luciano J. Costa, MD PhD, Yana Lutska, PharmD, Padma Bobba, Daniela Hoehn, Huiling Pei, PhD, Jon Ukropec, PhD, Ming Qi, MD PhD, Thomas S. Lin, MD PhD, Paul G. Richardson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–49.
https://doi.org/10.1182/blood-2020-137105
Published: 2020
Journal Articles

Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of Griffin after 12 Months of Maintenance Therapy

Jonathan L. Kaufman, MD, Jacob P. Laubach, Douglas Sborov, MD MS, Brandi Reeves, MD, Cesar Rodriguez, MD, Ajai Chari, Rebecca W. Silbermann, MD, Luciano J. Costa, MD PhD, Larry D. Anderson, Jr., MD PhD, Nitya Nathwani, MD, Nina Shah, MD, Yvonne A. Efebera, MD MPH, Sara A. Holstein, MDPhD, Caitlin Costello, Andrzej Jakubowiak, MD PhD, Tanya M. Wildes, MD MSCI, Robert Z. Orlowski, MDPhD, Kenneth H. Shain, MD PhD, Andrew J. Cowan, Yana Lutska, PharmD, Padma Bobba, Huiling Pei, PhD, Jon Ukropec, PhD, Jessica Vermeulen, MD PhD, Thomas S. Lin, MD PhD, Paul G. Richardson, MD, Peter M. Voorhees
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-137109
Published: 2020
Journal Articles

Integrating Touchscreen-Based Geriatric Assessment and Frailty Screening for Adults with Multiple Myeloma to Drive Personalized Treatment Decisions

Nitya Nathwani, MD, Supriya G. Mohile, MD MS, Sandra Kurtin, PhD, ANP-C, AOCN, Debra Wujcik, PhD, Susie Owenby, Matthew Dudley, William Dudley, PhD, Tanya M. Wildes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3443.
https://doi.org/10.1182/blood-2019-130245
Published: 2019
Journal Articles

Ixazomib or Lenalidomide Maintenance Following Autologous Stem Cell Transplantation and Ixazomib, Lenalidomide, and Dexamethasone (IRD) Consolidation in Patients with Newly Diagnosed Multiple Myeloma: Results from a Large Multi-Center Randomized Phase II Trial

Ravi Vij, MBBS, Thomas G. Martin, III, MD, Nitya Nathwani, MD, Mark A. Fiala, BS, Feng Gao, PhD, Abhinav Deol, MD, Francis K. Buadi, MB, CHB, Jonathan L. Kaufman, MD, Craig C Hofmeister, MDMPH, Tara K. Gregory, MD, Jesus G. Berdeja, MD, Ajai Chari, MD, Ashley E. Rosko, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 602.
https://doi.org/10.1182/blood-2019-130644
Published: 2019
Journal Articles

Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Griffin Study Update

Peter M. Voorhees, MD, Jonathan L. Kaufman, MD, Jacob P. Laubach, MD, Douglas W. Sborov, MD MSc, Brandi Reeves, MD, Cesar Rodriguez, MD, Ajai Chari, MD, Rebecca W. Silbermann, MD, Luciano J. Costa, MD PhD, Larry D. Anderson, MD PhD, Nitya Nathwani, MD, Nina D. Shah, MD, Yvonne A. Efebera, MD MPH, Caitlin L. Costello, MD, Andrzej Jakubowiak, MD PhD, Tanya M. Wildes, MD, Robert Z. Orlowski, MD PhD, Kenneth H. Shain, MD PhD, Andrew J. Cowan, MD, Sean Murphy, Yana Lutska, PharmD, Huiling Pei, PhD, Jon Ukropec, PhD, Jessica Vermeulen, MD PhD, Carla de Boer, Daniela Hoehn, MD PhD, Thomas S. Lin, MD PhD, Paul G. Richardson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 691.
https://doi.org/10.1182/blood-2019-123465
Published: 2019
Journal Articles

First-in-Human Imaging of Multiple Myeloma Using Copper-64-Labeled Daratumumab: Preliminary Results

Amrita Y. Krishnan, MD, Vikram Adhikarla, PhD, Ammar Chaudhry, MD, Joycelynne Palmer, PhD, Erasmus K Poku, PhD, Van Eric Biglang-awa, PharmD, Nicole Bowles, Nitya Nathwani, MD, Michael Rosenzweig, MD, Firoozeh Sahebi, MD, Chatchada Karanes, MD, Jennifer Simpson, James F Sanchez, PhD, David Yamauchi, MD, Maria Parayno, MD, Arnab Chowdhury, PhD, Enrico Caserta, PhD, Anna Wu, PhD, Stephen J Forman, MD, David Colcher, PhD, Paul Yazaki, PhD, John E. Shively, PhD, Flavia Pichiorri, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4394.
https://doi.org/10.1182/blood-2019-126080
Published: 2019
Journal Articles

Repurposing Leflunomide for Relapsed/Refractory Multiple Myeloma: Final Analysis of a Phase 1 Study

Michael Rosenzweig, Joycelynne Palmer, Ni-Chun Tsai, Ralf Buettner, PhD, Lupe Duarte, Myo Htut, Chatchada Karanes, Nitya Nathwani, MD, Flavia Pichiorri, PhD, Firoozeh Sahebi, Tim Synold, Xiwei Wu, James F Sanchez, Amrita Krishnan, MD, Stephen J Forman, Steven T Rosen
Journal: Blood
Blood (2018) 132 (Supplement 1): 2007.
https://doi.org/10.1182/blood-2018-99-120042
Published: 2018
Journal Articles

Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi-Center Phase II Trial

Ravi Vij, MBBS, Nitya Nathwani, MD, Thomas G. Martin, III, MD, Mark A. Fiala, BS, Abhinav Deol, MD, Francis K. Buadi, MB, CHB, Jonathan L Kaufman, MD, Craig C Hofmeister, MDMPH, Tara Gregory, MD, Jesus G. Berdeja, MD, Ajai Chari, MD, Ashley E. Rosko, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 123.
https://doi.org/10.1182/blood-2018-99-109920
Published: 2018
Journal Articles

Efficacy and Updated Safety Analysis of a Safety Run-in Cohort from Griffin, a Phase 2 Randomized Study of Daratumumab (Dara), Bortezomib (V), Lenalidomide (R), and Dexamethasone (D; Dara‐Vrd) Vs. Vrd in Patients (Pts) with Newly Diagnosed (ND) Multiple Myeloma (MM) Eligible for High‐Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

Peter M. Voorhees, MD, Cesar Rodriguez, MD, Brandi Reeves, MD, Nitya Nathwani, MD, Luciano J Costa, MD PhD, Yana Lutska, PharmD, Daniela Hoehn, MDPhD, Huiling Pei, PhD, Jon Ukropec, PhD, Ming Qi, MD PhD, Thomas Lin, MD PhD, Paul Richardson
Journal: Blood
Blood (2018) 132 (Supplement 1): 151.
https://doi.org/10.1182/blood-2018-151
Published: 2018
Journal Articles

Melphalan-Based Regimen Is a Safe and Effective Conditioning Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Older Adults (≥70 years) with Hematological Malignancies

Monzr M. Al Malki, MD, Nitya Nathwani, MD, Dongyun Yang, PhD, Karamjeet S. Sandhu, MD, Jaroslava Salman, MD, Michelle Rouse, Sally Mokhtari, PhD, Thai Cao, MD, Sanjeet Dadwal, MD, Matthew Mei, MD, Haris Ali, MD, Saro H. Armenian, DO,MPH, Pablo Parker, MD, Joseph C. Alvarnas, MD, Eileen P. Smith, MD, Margaret R. O'Donnell, MD, David S. Snyder, MD, Guido Marcucci, MD, Auayporn P. Nademanee, MDBS, Stephen J. Forman, MD FACP, Anthony S. Stein, MD, Ryotaro Nakamura, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1995.
https://doi.org/10.1182/blood.V130.Suppl_1.1995.1995
Published: 2017
Journal Articles

A Phase I/II Trial of Ixazomib (Ix), Pomalidomide (POM), and Dexamethasone (DEX), in Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients: Responses in Double/Triple Refractory Myeloma and Poor Risk Cytogenetics

Amrita Krishnan, Prashant Kapoor, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS, Shaji Kumar, MD, Sagar Lonial, MD FACP, Myo Htut, MD, Chatchada Karanes, MD, Nitya Nathwani, MD, Michael Rosenzweig, MD, Firoozeh Sahebi, MD, George Somlo, MD FACP, Lupe Duarte, CTA, Stephen J. Forman, MD, James F Sanchez, PhD, Jesus G. Berdeja, MD
Journal: Blood
Blood (2016) 128 (22): 3316.
https://doi.org/10.1182/blood.V128.22.3316.3316
Published: 2016
Journal Articles

Integrating a Touchscreen-Based Assessment and Screening Tool for Adults with Multiple Myeloma

Tanya M Wildes, MD, Carrie T. Stricker, PhD RN, William Dudley, PhD, Diana Harris, MBe, PhD, Nitya Nathwani, MD, Jeannine Brant, PhD APRN, AOCN, Sandra E. Kurtin, RN, MS, AOCN, ANP-C, Arti Hurria
Journal: Blood
Blood (2016) 128 (22): 2373.
https://doi.org/10.1182/blood.V128.22.2373.2373
Published: 2016
Journal Articles

Combination of Dasatinib with Conventional Chemotherapy Is Associated with a High Response Rate in High Risk Acute Myeloid Leukemia (AML)

Ahmed Aribi, MD, Cedric Dos Santos, PhD, Margaret O' Donnell, MD, Anthony S. Stein, MD, Allen Lin, Joycelynne M. Palmer, PhD, Meng Zhuo, David Snyder, MD, Haris Ali, MD, Robert Chen, Leslie L. Popplewell, MD, Nitya Nathwani, MD, Samer K Khaled, MD, Amandeep Salhotra, MD, Alex Herrera, MD, Ibrahim Aldoss, MD, Eileen P. Smith, MD, Guido Marcucci, MD, Stephen J. Forman, MD, Ravi Bhatia, MD
Journal: Blood
Blood (2015) 126 (23): 3743.
https://doi.org/10.1182/blood.V126.23.3743.3743
Published: 2015
Journal Articles

Brentuximab Vedotin As First Line Salvage Therapy in Relapsed/Refractory HL

Robert W. Chen, MD, Joycelynne Palmer, PhD, Tanya Siddiqi, MD, Sandra H. Thomas, PhD, Young Kim, MD, Chen T Binhong, MD, Amrita Krishnan, MD, Nitya Nathwani, MD, Ji-Lian Cai, MD, PhD, Michelle Mott, RN, Deron Matsuoka, BS, Stephen J Forman, MD
Journal: Blood
Blood (2012) 120 (21): 3699.
https://doi.org/10.1182/blood.V120.21.3699.3699
Published: 2012